Aarti Pharmalabs Past Earnings Performance
Past criteria checks 3/6
Aarti Pharmalabs has been growing earnings at an average annual rate of 42.2%, while the Pharmaceuticals industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 38.7% per year. Aarti Pharmalabs's return on equity is 11.7%, and it has net margins of 10.6%.
Key information
42.2%
Earnings growth rate
46.8%
EPS growth rate
| Pharmaceuticals Industry Growth | 17.5% |
| Revenue growth rate | 38.7% |
| Return on equity | 11.7% |
| Net Margin | 10.6% |
| Next Earnings Update | 13 May 2024 |
Revenue & Expenses BreakdownBeta
How Aarti Pharmalabs makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 18,319 | 1,945 | 1,394 | 0 |
| 30 Sep 23 | 18,548 | 1,895 | 1,380 | 0 |
| 30 Jun 23 | 19,462 | 1,887 | 1,325 | 0 |
| 31 Mar 23 | 19,452 | 1,935 | 1,349 | 0 |
| 31 Dec 22 | 20,601 | 2,118 | 1,391 | 0 |
| 30 Sep 22 | 21,885 | 2,252 | 1,469 | 0 |
| 30 Jun 22 | 16,573 | 1,741 | 1,156 | 0 |
| 31 Mar 22 | 11,999 | 1,223 | 852 | 0 |
| 31 Mar 21 | 0 | 0 | 0 | 0 |
Quality Earnings: AARTIPHARM has high quality earnings.
Growing Profit Margin: AARTIPHARM's current net profit margins (10.6%) are higher than last year (10.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AARTIPHARM's earnings have grown significantly by 42.2% per year over the past 5 years.
Accelerating Growth: AARTIPHARM's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: AARTIPHARM had negative earnings growth (-8.1%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (23.4%).
Return on Equity
High ROE: AARTIPHARM's Return on Equity (11.7%) is considered low.